Agile Therapeutics to Present at Upcoming March Investor Conferences
Agile Therapeutics, Inc. (Nasdaq: AGRX) announced that Chairman and CEO Al Altomari will present at two upcoming investor conferences in March 2021. The events include the H.C. Wainwright Global Life Sciences Conference, available on-demand starting March 9, 2021, and the Oppenheimer 31st Annual Virtual Healthcare Conference on March 17, 2021. Webcasts of the presentations will be accessible on Agile's website for 30 days following each conference. Agile Therapeutics focuses on women's healthcare, offering innovative contraceptive options like their product Twirla®.
- None.
- None.
PRINCETON, N.J., March 05, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will present at two investor conferences in March.
- H.C. Wainwright Global Life Sciences Conference
- On demand beginning Tuesday, March 9, 2021 at 7:00 a.m. ET
- Oppenheimer 31st Annual Virtual Healthcare Conference
- Wednesday, March 17, 2021 at 8:40 a.m. ET
Presentations from each conference will be webcast on the Investors section of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. Each archived webcast will be available for 30 days.
About Agile Therapeutics, Inc.
Agile Therapeutics is a forward-looking women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com
FAQ
What are the dates and details of Agile Therapeutics' investor presentations in March 2021?
Where can I watch Agile Therapeutics' investor conference presentations?
What is Agile Therapeutics focused on?
What is Twirla® and how does it work?
